133 related articles for article (PubMed ID: 38284724)
1. Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues.
Raia S; Chiloiro S; Giampietro A; Maratta MG; Attili F; Brizi MG; Rufini V; De Marinis L; Pontecorvi A; Rindi G; Schinzari G; Bianchi A
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38284724
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Hayes AR; Crawford A; Al Riyami K; Tang C; Bomanji J; Baldeweg SE; Wild D; Morganstein D; Harry A; Grozinsky-Glasberg S; Oleinikov K; Khoo B; Caplin ME; Nicolas GP; Grossman AB
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4903-e4916. PubMed ID: 34379772
[TBL] [Abstract][Full Text] [Related]
4. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues.
Kunikowska J; Ziemnicka K; Pawlak D; Ruchała M; Kolasa A; Janicka-Jedyńska M; Woźniak A; Mikołajczak R; Królicki L
Endokrynol Pol; 2016; 67(1):68-71. PubMed ID: 26884118
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma.
Dadgar H; Jafari E; Ahmadzadehfar H; Rekabpour SJ; Ravanbod MR; Kalantarhormozi M; Nabipour I; Assadi M
Ann Endocrinol (Paris); 2023 Feb; 84(1):45-51. PubMed ID: 36126757
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases.
Castroneves LA; Coura Filho G; de Freitas RMC; Salles R; Moyses RA; Lopez RVM; Pereira MAA; Tavares MR; Jorge AAL; Buchpiguel CA; Hoff AO
J Clin Endocrinol Metab; 2018 Sep; 103(9):3250-3259. PubMed ID: 29846642
[TBL] [Abstract][Full Text] [Related]
9. Disease Control on Lanreotide Autogel® 120 mg in a Patient with Metastatic Gastrinoma: A Case Report.
Aerts M; Reynaert H
Case Rep Gastroenterol; 2017; 11(3):616-623. PubMed ID: 29430219
[TBL] [Abstract][Full Text] [Related]
10. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bilateral somatostatin receptor expression in mediastinal lymph nodes ("chimney sign") in occult metastatic medullary thyroid cancer: a typical site of tumour manifestation?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Becker H; Becker W
Eur J Nucl Med; 1997 Feb; 24(2):184-91. PubMed ID: 9021116
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma (MTC): unusual metastatic sites.
Kazakou P; Simeakis G; Alevizaki M; Saltiki K
Endocrinol Diabetes Metab Case Rep; 2021 Sep; 2021():. PubMed ID: 34551391
[TBL] [Abstract][Full Text] [Related]
14. 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.
Nicolini S; Ambrosini V; Fantini L; Fanti S
Clin Nucl Med; 2012 Jun; 37(6):591-2. PubMed ID: 22614194
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
Thyroid; 2010 May; 20(5):527-33. PubMed ID: 20450432
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of
Parghane RV; Naik C; Talole S; Desmukh A; Chaukar D; Banerjee S; Basu S
Head Neck; 2020 Mar; 42(3):401-416. PubMed ID: 31755622
[TBL] [Abstract][Full Text] [Related]
17. Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.
Greco C; Brigante G; Taliani E; Corrado S; Simoni M; Madeo B
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778356
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
Díez JJ; Iglesias P
J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
[TBL] [Abstract][Full Text] [Related]
19. Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on
Duarte PS; de Castroneves LA; Sado HN; Sapienza MT; de Oliveira Hoff AAF; Buchpiguel CA
Nucl Med Mol Imaging; 2018 Aug; 52(4):318-323. PubMed ID: 30100945
[TBL] [Abstract][Full Text] [Related]
20. Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.
Skoura E
Int J Endocrinol Metab; 2013 Oct; 11(4):e8156. PubMed ID: 24719630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]